Comparing oxygen delivery methods for children with obstructive sleep apnea
Official title: Comparison of a Demand Oxygen Delivery to Continuous Flow for Administration of Oxygen During Sleep
Run by Children's Hospital Medical Center, Cincinnati · NCT06609694 · Data updated 2026-11-12
This study is testing whether two different ways of delivering oxygen can help children with Down syndrome who have moderate to severe obstructive sleep apnea breathe better during sleep.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 17 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Status | Recruiting |
| Started | January 9, 2023 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2028 |
| Registry record updated | January 7, 2026 |
| Trial ID | NCT06609694 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children aged 5-17 years with Down syndrome or obstructive sleep apnea and an obstructive apnea hypopnea index between 5-40 per hour.
✕Probably not a fit
Patients currently using CPAP with documented compliance or those with significant hypoxia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study conducts a randomized control trial to compare two methods of oxygen delivery—continuous flow and pulse flow—in children with Down syndrome suffering from moderate to severe obstructive sleep apnea. The trial involves 15 participants from Cincinnati Children's Hospital and Children's Hospital of Los Angeles, where each child will undergo two polysomnographies to assess the effectiveness of each method. The goal is to gather data that could inform a larger project aimed at evaluating the impact of oxygen treatment on obstructive apnea frequency and related neurocognitive and cardiac outcomes. This pilot study is crucial for understanding the potential benefits of pulse flow oxygen concentrators in pediatric patients.
Why it matters
Potential benefit: If successful, this study could provide a more effective and portable oxygen delivery method for children with obstructive sleep apnea, improving their overall health and quality of life.
How similar studies have gone: While pulse flow oxygen concentrators have been used in adults, this approach is novel in the pediatric population, particularly for those with Down syndrome.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 5-17 years with or without Down Syndrome (DS). 2. Children with obstructive sleep apnea (OSA) and obstructive apnea hypopnea index (OAHI) 5-40 / hour: The rationale for selecting this range of OAHI is that a large number of children with DS with this range of OSA severity are untreated for months to years. It is important to understand the response to oxygen across the spectrum of disease severity. Notably, children with severe disease are left with few options (e.g., tracheostomy). 3. Absence of clinically significant hypoxia defined as oxygen saturation \< 88% for 5 minutes or episodic desaturation to 60% as these levels would otherwise identify children eligible to routinely receive oxygen. Exclusion Criteria: 1. Current CPAP use with documented compliance (\> 4 hrs/ night; \> 70% of nights). 2. Oxygen saturation \< 90% at rest during wakefulness 3. Chronic daytime or nighttime use of supplemental oxygen. 4. Unable to participate in a Polysomnogram (PSG). 5. Enrolled or planning to enroll in another study that may conflict with protocol requirements or confound results in this trial.
Where it's running
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting
Study contacts
- Principal investigator: Raouf Amin, MD — Children's Hospital Medical Center, Cincinnati
- Study coordinator: Suzie Hicks, BS
- Email: suzie.hicks@cchmc.org
- Phone: 513-636-4944
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Night-to-night variability of physiological markers in home sleep apnea testing
This study tests how stable both traditional and novel sleep apnea markers are from one night to the next in people undergoing home sleep apnea testing.
-
Allogeneic HCT for Refractory sJIA in Children and Young Adults
This study tests whether donor blood-forming cell transplantation can help children and young adults with difficult-to-treat systemic JIA, including those with lung involvement.
-
Proton MRI of Musculoskeletal and Lung Health
This study tests MRI techniques to take clearer pictures of the lungs in healthy people and those with lung, muscle, or bone conditions.
-
See how well the lungs distribute dissolved xenon gas during MRI in HSCT patients and others
This study tests a special MRI method using hyperpolarized xenon gas to visualize how gas and dissolved xenon move through the lungs in people who have HSCT, respiratory issues, or are healthy controls.
-
Semaglutide for teens with autism and obesity
This 6-month, two-arm study tests whether semaglutide can help reduce BMI in adolescents 12-18 with autism and obesity, alongside lifestyle counseling.
-
FST Decision Support to Help Timely Therapy for Kids with AKI Risk
This study tests whether adding a clinical decision support tool to the electronic medical record helps clinicians use the furosemide stress test in critically ill children at high risk for severe AKI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.